The contribution of the immune system to prion diseases

Drug Discovery Today: Disease Mechanisms

Volumn 1, Issue 3, 2004, Pages 351-356

  Forloni, Gianluigi ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PRP; PRION PROTEIN; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BONE MARROW CELL; BOVINE SPONGIFORM ENCEPHALOPATHY; CELL DIFFERENTIATION; CREUTZFELDT JAKOB DISEASE; DENDRITIC CELL; FATAL FAMILIAL INSOMNIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KURU; LYMPHOID ORGAN; MACROPHAGE; NONHUMAN; PRION DISEASE; RETICULOENDOTHELIAL SYSTEM; REVIEW; SCRAPIE; T LYMPHOCYTE;

EID: 23744474947     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.11.001     Document Type: Review

References (49)

1. Prusiner, S.B. (2001) Shattuck lecture - neurodegenerative diseases and prions. N. Engl. J. Med. 344, 1516-1526
2. Collins, S.J. et al. (2004) Transmissible spongiform encephalopathies. Lancet 363, 51-61
3. Bruce, M.E. et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501
4. Tagliavini, F. et al. (2001) Studies on peptide fragments of prion proteins. In Advances in Protein Chemistry (Richards, F.M. and Eisenberg, D.S., eds), pp. 171-202, Academic Press
5. Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144
6. Legname, G. et al. (2004) Synthetic mammalian prions. Science 305, 673-676
7. Bueler, H. et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347
8. Gajdusek, D.C. et al. (1966) Experimental transmission of a Kura-like syndrome to chimpanzees. Nature 209, 794-796
9. Herzog, C. et al. (2004) Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 363, 422-428
10. Fraser, H. and Dickinson, A.G. (1970) Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226, 462-463
11. Kovacs, G.G. et al. (2004) Complement activation in human prion disease. Neurobiol. Dis. 15, 21-28
12. Aucouturier, P. and Carnaud, C. (2002) The immune system and prion diseases: a relationship of complicity and blindness. J. Leukoc. Biol. 72, 1075-1083
13. Davies, M.L. et al. (2004) Architecture of secondary lymphoid tissue in sheep experimentally challenged with scrapie. Immunology 111, 230-236
14. Lasmezas, C.I. et al. (1996) Immune system-dependent and independent replication of the scrapie agent. J. Virol. 70, 1292-1295
15. Klein, M. et al. (1997) A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687-690
16. Brown, K.L. et al. (1999) Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med. 5, 1308-1312
17. Klein, M. A. et al. (1998) PrP expression in B lymphocytes is not required for prioneuroinvasion. Nat. Med. 4, 1429-1433
18. Montrasio, F. et al. (2001) B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc. Natl. Acad. Sci. USA 98, 4034-4037
19. Mohan, J. et al. (2004) Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. J. Dermatol. Sci. 35, 101-111
20. Shlomchik, M.J. et al. (2001) Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells. Proc. Natl. Acad. Sci. USA 98, 9289-9294
21. Montrasio, F. (2000) Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259
22. Mabbott, N.A. et al. (2003) Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77, 6845-6854
23. Aguzzi, A. et al. (2003) Immune system, and peripheral nerves in propagation of prions to CNS. Br. Med. Bull. 66, 141-159
24. Andreoletti, O. et al. (2000) Early accumulation of PrPSc in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J. Gen. Virol. 81, 3115-3126
25. Huang, F.P. et al. (2002) Migrating intestinal dendritic cells transport PrP(Sc) from the gut. J. Gen. Virol. 83, 267-271
26. Oldstone, M.B. et al. (2002) Lymphotoxin-alpha- and lymphotoxin-beta- deficient mice differ in susceptibility to scrapie: evidence against dendritic cell involvement in neuroinvasion. J. Virol. 76, 4357-4363
27. Prinz, M. et al. (2002) Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc. Natl. Acad. Sci. USA 99, 919-924
28. Klein, M. A. et al. (2001) Complement facilitates early prion pathogenesis. Nat. Med. 7, 488-492
29. Kovacs, G.G. et al. (2002) Mutations of the prion protein gene phenotypic spectrum. J. Neurol. 249, 1567-1582
30. Eikelenboom, P. et al. (2002) Neuroinflammation in Alzheimer's disease and prion disease. Glia 40, 232-239
31. Marella, M. and Chabry, J. (2004) Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 24, 620-627
32. Forloni, G. et al. (1994) A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur. J. Neurosci. 6, 1415-1422
33. Williams, A. et al. (1997) PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp. Neurol. 144, 433-438
34. Bate, C. et al. (2002) Temporal and spatial relationship between the death of PrP-damaged neurones and microglial activation. Neuroreport 13, 1695-1700
35. Weiner, H.L. and Selkoe, D.J. (2002) Inflammation and therapeutic vaccination in CNS diseases. Nature 420, 879-884
36. Schenk, D. (2002) Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Nat. Rev. Neurosci. 3, 824-828
37. Gabizon, R. et al. (1988) Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. USA 85, 6617-6621
38. Horiuchi, M. and Caughey, B. (1999) Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193-3203
39. Peretz, D. et al. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743
40. Enari, M. et al. (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98, 9295-9299
41. Sigurdsson, E.M. et al. (2003) Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci. Lett. 336, 185-187
42. Sigurdsson, E.M. et al. (2002) Immunization delays the onset of prion disease in mice. Am. J. Pathol. 161, 13-17
43. Schwarz, A. et al. (2003) Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci. Lett. 35, 187-189
44. Rosset, M.B. et al. (2004) Breaking immune tolerance to the prion protein using prion protein peptides plus oligodeoxynucleotide-CpG in mice. J. Immunol. 172, 5168-5174
45. Tal, Y. et al. (2003) Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice. J. Neurosci. Res. 71, 286-290
46. Sethi, S. et al. (2002) Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360, 229-230
47. Heikenwalder, M. et al. (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 10, 187-192
48. White, A.R. et al. (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80-83
49. Glatzel, M. et al. (2004) Variant Creutzfeldt-Jakob disease: between lymphoid organs and brain. Trends Microbiol. 12, 51-53